Abstract
BACKGROUND Early childhood has increasingly been recognized as an important neurodevelopmental period. However, the links between specific forms of early educational activities and cognition and mental health remain unclear.
METHODS A large-scale analysis on the attainments of childhood Reading for Pleasure (early RfP) and its relationship with young adolescent measures of cognition, mental health and brain structure was conducted, using linear mixed-effects model, structural equation and mediation analyses. Participants were from the Adolescent Brain and Cognitive Development (ABCD) study, a USA national cohort (n=11,878). A two-sample Mendelian randomization (MR) analysis using genetic instruments from two independent genome-wide association studies (GWAS) based on ABCD and GWAS meta-analyses including UK-biobank datasets were conducted to assess potential causal inference.
RESULTS Early RfP was positively associated with cognitive assessments, which in contrast, was negatively associated with dimensional psychiatric problems in young adolescents. MR analysis revealed a beneficial relationship between early RfP and later-life cognitive performance, and a trend towards a protective relationship between early RfP and later-life attention disorder. Brain regions in which larger cortical areas were positively associated with early RfP included the superior temporal, prefrontal, left angular, parahippocampal, right anterior cingulate (ACC), occipital, supramarginal and orbital regions and subcortical ventral diencephalon (DC), thalamus, and brainstem volumes. Mediation analysis indicated that the brain regions significantly mediated the effects of early RfP with better cognitive performance and lower psychiatric problems.
INTERPRETATION Our results highlight the importance of encouraging RfP in young children during the critical early childhood stage, as it was associated with beneficial outcomes for cognition, mental health, and brain structure later in life.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was supported by the following grants: Wellcome Trust Collaborative Award (200181/Z/15/Z), and the research is conducted within the NIHR Cambridge Biomedical Research Centre (BRC) (Mental Health Theme and Neurodegeneration Theme) and the NIHR MedTech and in vitro diagnostic Co-operative (MIC) (granted to Dr Sahakian). National Key R&D Program of China (No. 2019YFA0709502), National Key R&D Program of China (No. 2018YFC1312904), Shanghai Municipal Science and Technology Major Project (No. 2018SHZDZX01), ZJ Lab, Shanghai Center for Brain Science and Brain-Inspired Technology, and the 111 Project (No. B18015) (granted to Dr Feng). National Natural Sciences Foundation of China (No. 82071997), the Shanghai Rising-Star Program (No. 21QA1408700) and Natural Science Foundation of Shanghai (No. 18ZR1404400) (granted to Dr Cheng). National Natural Science Foundation of China (No. 31700892) (granted to Dr Sun).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Centralized institutional review board (IRB) approval was obtained from the University of California, San Diego IRB. All 21 study sites of the ABCD research obtained approval from their local IRBs. All of the participants had signed written consent forms (for parents or caregivers) and informed consent forms (for young adolescents) before participation in the study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
This study was conducted under the ABCD NDA data permission number of 9143 (DAR ID).
